Team Takes Top Honors at Nokia Sensing XCHALLENGE Awards With Technology Poised to Launch an Era of Personalized Nanomedicine and Mobile Health Care SANTA CLARA, CA--(Marketwired - Oct 2, 2013) - Nanobiosym Health RADAR, a Boston-based research incubator institute led by Dr. Anita Goel, was awarded the $525,000 Grand Prize in the first competition of the Nokia Sensing XCHALLENGE for their Gene-RADAR sensing technology that will transform the way health care is delivered by enabling personalized diagnostic testing. The Gene-RADAR platform analyzes a drop of blood, saliva or other body fluid placed on a nanochip and inserted into a mobile device, which then detects the presence or absence of a disease's pathogen in less than an hour, with the same accuracy available only in a diagnostic lab.The technology was developed to be easy-to-use and does not require overhead infrastructure, such as electricity or running water, which can lead to widespread adoption by developing countries. Nanobiosym has already demonstrated custom applications for E. coli and HIV/AIDS with potential applications across the entire spectrum of health care including diagnosis, monitoring, drug development, companion diagnostics, and personalized nanomedicine. "We're thrilled that the Nokia Sensing XCHALLENGE helped provide a platform for Nanobiosym and the … Continue reading →

Molly Pre-Stem Cell Treatment Video #2 of 3 Molly Pre-StemCell Treatment #2 of 3. By: Thomas Beall … Continue reading →

Molly Pre-Stem Cell Treatment Video #3 of 3 Molly Pre-Stem Cell Treatment #3 of 3. By: Thomas Beall … Continue reading →

Top ranked UFC bantamweight challenger Cat Zingano has been out of action for several months due to an injury to her right knee. That injury is on the mend, but it has led to issues with her left knee, for which Zingano will have a procedure on Thursday. I am about three and a half months out (from the original injury), Zingano said on UFC Tonight. I went to my doctor on Monday. He said that Im right on track, so I should be coming back in another four months, something like March or April. That is, of course, as long as the issues with her left knee can be rectified within that same time frame, which her doctor believes is the case. Dr. Ronald S. Kvitne of the Kerlan-Jobe Orthopedic Clinic in Los Angeles on Monday told Zingano that if there was a tear in her left meniscus, as expected, that if they act quickly, it shouldnt extend the rehab time of her original injury. Dr. Kvitne was initially thinking a surgery would be necessary, but Zingano on Wednesday indicated that Thursdays procedure would instead involve a stem cell treatment. My left knee, because I think for the compensation … Continue reading →

PERTH, Australia, Oct. 2, 2013 /PRNewswire/ -- Regenerative medicine company, Orthocell Limited (Orthocell), today announced the results of its unprecedented and successful clinical trial for the treatment of tendon injuries using its patented stem cell technology. Tendon injuries are one of the most common causes of occupational and sporting disability and current clinical treatments are only moderately effective. Orthocell's new technique is known as Autologous Tenocyte Implantation (Ortho-ATIT) and involves biopsy of the patient's own healthy tendon, isolation and cultivation of tendon stem cells from the biopsy in a special laboratory and then injection of these cells back to the injured tendon. The process takes about 20-minutes and is less invasive than surgery. The company has received international profiling and recognition in the prestigious American Journal of Sports Medicine (AJSM), with a peer reviewed publication of the world first study on Ortho-ATIT stem cell technology for regeneration of damaged human tendon. The AJSM, which is ranked as the world's number one journal for orthopaedics and sports medicine, published outcomes of the clinical trial last week. The data demonstrates that Orthocell's novel technology for repairing tendons was a safe and effective procedure that enables a reduction in pain and repairs tendon … Continue reading →

Orange County, CA (PRWEB) October 02, 2013 The leading regenerative medicine clinic on the West Coast, TeleHealth, is now offering treatment with stem cells for shoulder arthritis and tendonitis. The treatments are performed as an outpatient and include autologous stem cell treatments that are derived from either bone marrow or fat along with PRP therapy. The treatments are often covered by insurance, and the doctors are Board Certified with years of experience in stem cell therapy. Call (888) 828-4575 for more information and scheduling. Shoulder injuries are not frustrating just for high level athletes. Even individuals who perform overhead work, are involved in a car accident or simply dealing with degenerative arthritis may suffer from chronic shoulder pain. Traditional treatments may provide pain relief, however, prior to undergoing surgery regenerative medicine treatments should be considered with stem cell therapy. TeleHealth offers Board Certified stem cell doctors treating shoulder pain with several options for stem cell therapy. This may include rotator cuff tendonitis, labral tears, shoulder joint arthritis, biceps tendonitis, rotator cuff tears or impingement syndrome. These may take many months to heal without stem cell treatment and there is a distinct possibility the injury may not heal due to the … Continue reading →

Miami, FL (PRWEB) October 02, 2013 Regenestem, a division of the Global Stem Cells Group, Inc., this week announced plans to create a stem cell treatment center in Cancun, Mexico that will offer the most advanced protocols and techniques in cellular medicine to patients from around the world. The new Regenestem team in Cancun will be led by Rafael Moguel, M.D., a specialist in cardiology and interventional cardiology from Clinic of The Heart facility in Los Cabos, Mexico. An advocate and pioneer in the use of stem cell therapies to treat a wide variety of conditions, Moguel is joined by a team of talented and respected physicians from other Latin American countries and the U.S. to provide state-of-the-art patient treatment and follow-up under the Regenestem brand. Regenestem currently offers stem cell treatments for arthritis, autism, chronic obstructive pulmonary disease (COPD), diabetes and multiple sclerosis at various facilities including Far Eastern University in Manila, Philippines, University of Nuevo Leon (University Hospital) in Monterrey, Mexico, and University Maimonides in Buenos Aires, Argentina. Committed to the highest of standards in service and technology, expert and compassionate care, and a philosophy of exceeding the expectations of its international patients, Regenestem provides an international staff … Continue reading →